Physician profile
Daniel Blake Logan
NPI 1699771865
$83,311.64
in general payments reported to CMS, 2019-2025
30 companies · $2,589 in 2025
The $2,589 reported for 2025 was more than what 92% of Podiatrist providers received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $17K · 2020: $10K · 2021: $7,964 · 2022: $23K · 2023: $12K · 2024: $11K · 2025: $2,589.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $15K · Food and Beverage: $5,967 · Travel and Lodging: $2,993 · Consulting Fee: $2,349.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $14,673.90 |
| Food and Beverage | $5,967.32 |
| Travel and Lodging | $2,993.43 |
| Consulting Fee | $2,349.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acumed LLC | $42,492.47 | 2021-2025 | Acumed, Osteomed, Acumed |
| Flower Orthopedics Coporation | $11,281.09 | 2019-2022 | |
| Paragon 28, INC. | $10,004.72 | 2019 | |
| Stryker Corporation | $8,830.24 | 2019-2024 | Prophecy, Citrefix, Prostep |
| Cdc Medical LLC | $2,512.48 | 2019-2023 | |
| Wright Medical Technology, INC. | $1,935.48 | 2019-2020 | |
| Zimmer Biomet Holdings, INC. | $1,826.43 | 2019-2020 | |
| Novastep INC. | $1,286.99 | 2019-2021 | |
| Smith+Nephew, INC. | $925.53 | 2020-2025 | Grafix Pl, Stravix Pl, Stravix |
| Sanara Medtech INC. | $344.37 | 2024-2025 | Celleraterx, Celleraterx, Biasurge |
| Arteriocyte Medical Systems, INC. | $283.45 | 2019-2021 | |
| Treace Medical Concepts, INC. | $225.23 | 2025 | |
| Medline Industries Lp | $164.46 | 2019-2020 | |
| Pacira Pharmaceuticals Incorporated | $159.05 | 2019-2024 | Iovera, Zilretta, Exparel |
| Linvatec Corporation | $152.89 | 2024 | Biobrace 23mm |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Orthofix Medical, INC. | $140.13 | 2019-2023 | Truelok System, Tl-Hex Truelok Hexapod System |
| Organogenesis INC. | $124.57 | 2022-2025 | Puraply Wound Matrix, Puraply |
| Kerecis Limited | $116.45 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Arthrex, INC. | $106.32 | 2019 | |
| Gramercy Extremity Orthopedics LLC | $78.32 | 2025 | |
| Abbott Laboratories | $74.07 | 2023 | Eterna |
| In2bones USA, LLC | $53.11 | 2019 | |
| Crossroads Extremity Systems, LLC | $41.78 | 2020 | |
| Arthrosurface Incorporated | $40.67 | 2019 | |
| Medtronic, INC. | $26.06 | 2025 | Inceptiv |
| Medartis INC. | $24.55 | 2025 | Aptus |
| 4web, INC. | $22.31 | 2019 | |
| Tenex Health INC. | $19.95 | 2021 | |
| Integra Lifesciences Corporation | $13.13 | 2020 | |
| Microaire Surgical Instruments LLC | $5.34 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$200,000.00 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Logan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.